47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
49.41.Z - Road freight transport
82.99.Z - Other business support activities, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -8,4 | -76,4 | 423,3 | 654,1 |
EBITDA | -5,9 | -49,1 | 381,7 | 876,8 |
Short time liabilities | 387,1 | 463,6 | 214,3 | -53,8 |
Equity capital | -382,3 | -444,2 | -54,6 | 87,7 |
Operating profit (EBIT) | -5,9 | -49,1 | 381,7 | 876,8 |
Assets | 4,8 | 19,4 | 175,7 | 805,7 |
Net profit (loss) | -5,1 | -61,9 | 389,6 | 729,5 |
Cash | 0 | 0 | 0 | 0 |
Net income from sale | 0 | 0 | 90 | -∞ |
Liabilities and provisions for liabilities | 387,1 | 463,6 | 230,3 | -50,3 |
Working assets | 1 | 1,1 | 175,2 | 15 586,1 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 1,3 | 13,9 | -713,3 | -727,2 |
Equity capital to total assets | -8035,7 | -2289,4 | -31,1 | 2258,3 |
Gross profit margin | 470,4 | |||
EBITDA Margin | 424,1 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 869 | -2 147 482 779 |
Current financial liquidity indicator | 0.002553675090894103 | 0.002409545471891761 | 0.8174320459365845 | 0,8 |
Net dept to EBITDA | -64.12242889404297 | -9.405218124389648 | 0.5482011437416077 | 9,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane